: Pancreatitis ). If fasting triglycerides are elevated or become elevated during treatment, antilipemic therapy should be instituted, and if necessary, the dose of Targretin capsules reduced or suspended. In the 300 mg/m ²/day initial dose group, 60% of patients were given lipid lowering drugs. Atorvastatin was used in 48% (73/152) of patients with CTCL. Because of a potential drug- drug interaction (see PRECAUTIONS : Drug-Drug Interactions), gemfibrozil is not recommended for use with Targretin ® capsules.
...
[ read more.. ]
Get A Second Opinion From...
|
